What stage does i&i Biotech Fund invest at?

i&i Biotech Fund invests at the Pre-Seed, Seed, Series A, Series B stages.

What is i&i Biotech Fund's typical check size?

i&i Biotech Fund typically writes checks of $150K – $2M.

Where is i&i Biotech Fund located?

i&i Biotech Fund is headquartered in Prague, CZ.

i&i Biotech Fund

Venture capital

Prague · Pre-Seed–Series B · 10 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into i&i Biotech Fund

131 people in our graph share verified history with the i&i Biotech Fund team — schools, employers, funds. One of them is your warm intro.

Will McGinnisunlockedknows Karel Kubias · together at Auburn University, College of Business (overlapped)

×2knows the team · via Merck Millipore, division of Merck KGaA

×8knows the team · via Auburn University, College of Business

knows the team · via Merck KGaA

✨ Fox Verdict

Investment thesis

i&i Bio backs Europe's next wave of early-stage life sciences startups that tackle unmet medical needs with strong science and a competitive edge. The fund supports founders from the very start, providing €150k for business creation, a sweet spot of €0.5M-€2M for growth, and reserved follow-on capital for standout portfolio companies. Its primary geographic focus is Central and Eastern Europe, while remaining open to ambitious teams across Europe. The fund is comfortable investing across drug discovery, medtech, diagnostics, and AI verticals, seeking founders with a clear edge and the ambition to scale their innovations globally.

Invests inAI & Machine Learning Biotech Digital Health Healthtech Medical Devices Europe Prague United States

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series B

Check

$150K – $2M

Prague, CZ

Instruments

Equity

Founded

2021

AUM

$48.6M

Team · 10 people

from the firm's website & curated & public directories

Ivan Vohlmuth· Founding Partner

Ivan has over 25 years of experience in fund management, VC, and PE, having overseen 100+ investments across CEE and the Baltics and held more than 30 board positions.

i•••@inibio.eureveal

Karel Kubias· Founding Partner· Prague, Czechiain

Karel has over 20 years of leadership experience in life sciences, pharma, and diagnostics, including serving as CEO of Merck's Czech subsidiary and Head of the EEMEA region at Merck Millipore.

Tomáš Maršálek· Founding Partner

Tomáš has over 15 years of experience in fund management, VC, and PE, and has served as CFO in several SMEs. His expertise includes valuations, due diligence, and tax structuring.

t•••@inibio.eureveal

Anela Vukoja· Partner

Anela brings over 10 years of experience across venture capital and management consulting, leading investments in drug development. She holds a PhD in Neuroscience and focuses on the DACH biotech ecosystem.

Barbora Šumová· Partner

Barbora focuses on investments in innovative biotech and medtech ventures, bringing experience in VC, startup creation, and portfolio management. She holds a Ph.D. in Immunology.

b•••@inibio.eureveal

Magdalena Marciniak· Advisor

Magdalena has over 10 years of experience in healthcare, biotech, and FMCG, specializing in business development, commercialization, and strategic partnerships. She is a Ph.D. candidate in project management.

Pavlína Koutecká· Associate

Pavlína is a computer scientist with expertise in AI and techbio, having built projects at the intersection of AI, life sciences, and healthcare, and contributed to research in mathematical optimization.

Simona Šandová· Office Manager

Simona has experience as an Office Manager and Junior Property Manager, handling training and conference organization, client and supplier communication, and administrative support.

Martin Kovalčík· Communication manager· Prague Metropolitan Areain

Martin handles PR and communication for the incubator. He previously spent nearly 13 years as a media coordinator at the Czech nonprofit People in Need and worked in several editorial offices, including as deputy editor-in-chief at Metro newspaper.

i•••@iniprague.comreveal

Simona Šandová· Office Manager· Prague, Czechiain

Simona oversees office operations at i&i Prague, with prior experience as an Office Manager and Junior Property Manager handling training, event organization, client communication, and administration.

s•••@iniprague.comreveal

Frequently asked questions

What stage does i&i Biotech Fund invest at?: i&i Biotech Fund invests at the Pre-Seed, Seed, Series A, Series B stages.
What is i&i Biotech Fund's typical check size?: i&i Biotech Fund typically writes checks of $150K – $2M.
What sectors does i&i Biotech Fund focus on?: i&i Biotech Fund focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
Where is i&i Biotech Fund located?: i&i Biotech Fund is headquartered in Prague, CZ.

Similar investors

Medical Excellence Capital

Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.

Ambix Venture Management, Llc

Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.

Voima Ventures

Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.

$216K – $3.2M

Cape Fear BioCapital

Cape Fear BioCapital is an early-stage venture capital firm backing therapeutics companies emerging from North Carolina's research institutions.

OCV Partners

OCV Partners is a Los Angeles based venture capital firm backing companies with differentiated technologies in compelling markets, led by former founders leveraging company-building experience.